Covering order for 261201600324P, 16-029956
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201600798P
- Awardee
-
Fujirebio US, Inc. UEI QLBVMG7KJ3W5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,510
Award facts
- Contract value 100% obligated
- $14,510.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Malvern, PA 19355, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Fujirebio US, Inc. on August 29, 2017, for $14,510.26, with completion due December 29, 2017. Performance is at Fujirebio's Malvern, Pennsylvania location. The order covers medical diagnostic equipment, reagents, assay kits, and related scientific instruments supporting the Institute's research requirements under the firm fixed-price structure of covering order 261201600324P, 16-029956.
Quick answers
Who was awarded contract HHSN261201600798P?
HHSN261201600798P was awarded to Fujirebio US, Inc. by National Cancer Institute (National Institutes of Health) on August 29, 2017.
How much is contract HHSN261201600798P worth?
The government has obligated $14,510 on HHSN261201600798P.
Was contract HHSN261201600798P competed?
The extent of competition for HHSN261201600798P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award